Clinical Trials Logo
  1. Home
  2. Coronary Syndrome
  3. NCT04881552

Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area — STEMI  

Coronary Syndrome Clinical Trial

Official title:
Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area

Clinical Trial Summary

The rapid and complete restoration of coronary flow is a key issue in the management of STEMI. Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy associated with antithrombotic drugs. In daily practice, it is not rare that some patients may achieve reopening of the culprit artery without undergoing any mechanical reperfusion therapy, which is called " spontaneous reperfusion ". The latter is associated with improved outcomes in several studies but none of these studies were done in the modern antithrombotic strategy area including new P2Y12 inhibitors. The aim of this study is to report the incidence, characteristics and outcomes of consecutive patients with STEMI admitted for coronary angiography with angiographic clinical evidence of spontaneous reperfusion in the modern medical antithrombotic strategy associated with primary PCI.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04881552
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date June 1, 2020
Completion date May 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT00982176 - Determinants of Cognitive Impairment After Acute Coronary Syndrome N/A
Recruiting NCT05600088 - Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina N/A
Recruiting NCT06273033 - Implementation of Contemporary Coronary CT Angiography in Clinical Practice
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Recruiting NCT05476991 - Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis Phase 3
Completed NCT05140317 - 5 Years Follow up of the SAPIEN 3 Valve From the DIRECTAVI Trial
Recruiting NCT06103357 - Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
Recruiting NCT04325867 - Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 N/A
Not yet recruiting NCT05300178 - Use of Various Configurations of Different Arterial Grafts in Total Arterial Revascularization
Completed NCT00769574 - Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome. N/A
Completed NCT00709709 - Medical Evaluation of Scanner in Coronary Syndrome N/A
Recruiting NCT06058182 - RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
Recruiting NCT04864457 - Multi-omics Study of Young Adults Coronary Syndrome Patients
Completed NCT04580017 - Prognostic Accuracy of the HEART Score in Undifferentiated Chest Pain: A Multicenter Validation Study
Recruiting NCT04206683 - Cerebral Oxygenation and Burst Suppression
Completed NCT03312179 - STEMI and Incretins Treatment N/A
Active, not recruiting NCT04936438 - Clinical Cohort Study - INTERCATH
Completed NCT03772613 - The Randomized OPTIMAL-ACT Trial Phase 2
Completed NCT04990791 - WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? Phase 4
Not yet recruiting NCT02516826 - The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Phase 2